Sleep
3
Pipeline Programs
3
Companies
5
Clinical Trials
2
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
3
Early DiscoveryClinical DevelopmentMarket
On Market (2)
Approved therapies currently available
U
LUMRYZApproved
sodium oxybate
Unknown Companyoral2023
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Jazz PharmaceuticalsCA - Palo Alto
2 programs1
sodium oxybatePhase 41 trial
Language of SleepinessN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Jazz Pharmaceuticalssodium oxybate
UNEEG Medical24/7 EEG™ SubQ
Jazz PharmaceuticalsLanguage of Sleepiness
Design TherapeuticsPrenaBelt
Design TherapeuticsPrenaBelt
Clinical Trials (5)
Total enrollment: 285 patients across 5 trials
Enhancing Slow Wave Sleep With Sodium Oxybate
Start: May 2007Est. completion: Jun 200860 patients
Phase 4Completed
Ultra Long-Term Sleep Monitoring Using UNEEG™ Medical 24/7 EEG™ SubQ
Start: Sep 2020Est. completion: Jul 202225 patients
N/ACompleted
Language of Sleepiness
Start: Mar 2020Est. completion: Mar 2021200 patients
N/AUnknown
Halifax PrenaBelt Trial
Start: Mar 2016Est. completion: Jan 2017
N/ACompleted
Ghana PrenaBelt Trial: A Positional Therapy Device to Reduce Still-Birth
Start: Sep 2015Est. completion: Jun 2016
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space